Signaling pathways mediating β3-adrenergic receptor-induced production of interleukin-6 in adipocytes

Molecular Immunology

Volumn 46, Issue 11-12, 2009, Pages 2256-2266

  Tchivileva, Inna E ^a   Tan, Kai Soo ^a   Gambarian, Maria ^c   Nackley, Andrea G ^a   Medvedev, Alexander V ^c   Romanov, Sergei ^c   Flood, Patrick M ^a,b   Maixner, William ^a   Makarov, Sergei S ^c   Diatchenko, Luda ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Attagene Inc   (United States)

Author keywords

Cytokine; Inflammation; Obesity; p38; PKC

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 1; ACTIVATING TRANSCRIPTION FACTOR 2; BETA 3 ADRENERGIC RECEPTOR; CCAAT ENHANCER BINDING PROTEIN; CRE RECOMBINASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE C; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION;

ACTIVATING TRANSCRIPTION FACTOR 1; ADIPOCYTES, WHITE; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DIOXOLES; GENE EXPRESSION REGULATION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; INTERLEUKIN-6; MICE; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE C; RECEPTORS, ADRENERGIC, BETA-3; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION;

EID: 67349269221     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.04.008     Document Type: Article

References (96)

1. Ammit A.J., Lazaar A.L., Irani C., O'Neill G.M., Gordon N.D., Amrani Y., Penn R.B., and Panettieri Jr. R.A. Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and beta-agonists. Am. J. Respir. Cell Mol. Biol. 26 (2002) 465-474
2. Baldwin Jr. A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14 (1996) 649-683
3. Bamshad M., Aoki V.T., Adkison M.G., Warren W.S., and Bartness T.J. Central nervous system origins of the sympathetic nervous system outflow to white adipose tissue. Am. J. Physiol. 275 (1998) R291-R299
4. Bastard J.P., Maachi M., Van Nhieu J.T., Jardel C., Bruckert E., Grimaldi A., Robert J.J., Capeau J., and Hainque B. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J. Clin. Endocrinol. Metab. 87 (2002) 2084-2089
5. Biber K., Pinto-Duarte A., Wittendorp M.C., Dolga A.M., Fernandes C.C., Von Frijtag Drabbe Kunzel J., Keijser J.N., de Vries R., Ijzerman A.P., Ribeiro J.A., Eisel U., Sebastiao A.M., and Boddeke H.W. Interleukin-6 upregulates neuronal adenosine A1 receptors: implications for neuromodulation and neuroprotection. Neuropsychopharmacology 33 (2008) 2237-2250
6. Bloom J.D., Dutia M.D., Johnson B.D., Wissner A., Burns M.G., Largis E.E., Dolan J.A., and Claus T.H. Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316, 243). A potent beta-adrenergic agonist virtually specific for beta 3 receptors. A promising antidiabetic and antiobesity agent. J. Med. Chem. 35 (1992) 3081-3084
7. Brockunier L.L., Candelore M.R., Cascieri M.A., Liu Y., Tota L., Wyvratt M.J., Fisher M.H., Weber A.E., and Parmee E.R. Human beta3 adrenergic receptor agonists containing cyanoguanidine and nitroethylenediamine moieties. Bioorg. Med. Chem. Lett. 11 (2001) 379-382
8. Buchwalter G., Gross C., and Wasylyk B. Ets ternary complex transcription factors. Gene 324 (2004) 1-14
9. Burysek L., and Houstek J. Beta-adrenergic stimulation of interleukin-1alpha and interleukin-6 expression in mouse brown adipocytes. FEBS Lett. 411 (1997) 83-86
10. Camargo Jr. C.A., Madden J.F., Gao W., Selvan R.S., and Clavien P.A. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 26 (1997) 1513-1520
11. Candelore M.R., Deng L., Tota L., Guan X.M., Amend A., Liu Y., Newbold R., Cascieri M.A., and Weber A.E. Potent and selective human beta(3)-adrenergic receptor antagonists. J. Pharmacol. Exp. Ther. 290 (1999) 649-655
12. Cao W., Luttrell L.M., Medvedev A.V., Pierce K.L., Daniel K.W., Dixon T.M., Lefkowitz R.J., and Collins S. Direct binding of activated c-Src to the beta 3-adrenergic receptor is required for MAP kinase activation. J. Biol. Chem. 275 (2000) 38131-38134
13. Cao W., Medvedev A.V., Daniel K.W., and Collins S. Beta-adrenergic activation of p38 MAP kinase in adipocytes: cAMP induction of the uncoupling protein 1 (UCP1) gene requires p38 MAP kinase. J. Biol. Chem. 276 (2001) 27077-27082
14. Cassel D., and Selinger Z. Mechanism of adenylate cyclase activation by cholera toxin: inhibition of GTP hydrolysis at the regulatory site. Proc. Natl. Acad. Sci. U.S.A. 74 (1977) 3307-3311
15. Chernogubova E., Cannon B., and Bengtsson T. Norepinephrine increases glucose transport in brown adipocytes via beta3-adrenoceptors through a cAMP, PKA, and PI3-kinase-dependent pathway stimulating conventional and novel PKCs. Endocrinology 145 (2004) 269-280
16. Collins S., Cao W., and Robidoux J. Learning new tricks from old dogs: beta-adrenergic receptors teach new lessons on firing up adipose tissue metabolism. Mol. Endocrinol. 18 (2004) 2123-2131
17. Cressman D.E., Greenbaum L.E., DeAngelis R.A., Ciliberto G., Furth E.E., Poli V., and Taub R. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274 (1996) 1379-1383
18. De Cesare D., and Sassone-Corsi P. Transcriptional regulation by cyclic AMP-responsive factors. Prog. Nucleic Acid Res. Mol. Biol. 64 (2000) 343-369
19. de Rooij J., Zwartkruis F.J., Verheijen M.H., Cool R.H., Nijman S.M., Wittinghofer A., and Bos J.L. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396 (1998) 474-477
20. Deak M., Clifton A.D., Lucocq L.M., and Alessi D.R. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J. 17 (1998) 4426-4441
21. Edwards M.R., Haas J., Panettieri Jr. R.A., Johnson M., and Johnston S.L. Corticosteroids and beta2 agonists differentially regulate rhinovirus-induced interleukin-6 via distinct Cis-acting elements. J. Biol. Chem. 282 (2007) 15366-15375
22. Eickelberg O., Pansky A., Mussmann R., Bihl M., Tamm M., Hildebrand P., Perruchoud A.P., and Roth M. Transforming growth factor-beta1 induces interleukin-6 expression via activating protein-1 consisting of JunD homodimers in primary human lung fibroblasts. J. Biol. Chem. 274 (1999) 12933-12938
23. Evans B.A., Papaioannou M., Hamilton S., and Summers R.J. Alternative splicing generates two isoforms of the beta3-adrenoceptor which are differentially expressed in mouse tissues. Br. J. Pharmacol. 127 (1999) 1525-1531
24. Fain J.N., Madan A.K., Hiler M.L., Cheema P., and Bahouth S.W. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145 (2004) 2273-2282
25. Fenteany G., Standaert R.F., Lane W.S., Choi S., Corey E.J., and Schreiber S.L. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268 (1995) 726-731
26. Fliers E., Kreier F., Voshol P.J., Havekes L.M., Sauerwein H.P., Kalsbeek A., Buijs R.M., and Romijn J.A. White adipose tissue: getting nervous. J. Neuroendocrinol. 15 (2003) 1005-1010
27. Fried S.K., Bunkin D.A., and Greenberg A.S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. 83 (1998) 847-850
28. Gerhardt C.C., Gros J., Strosberg A.D., and Issad T. Stimulation of the extracellular signal-regulated kinase 1/2 pathway by human beta-3 adrenergic receptor: new pharmacological profile and mechanism of activation. Mol. Pharmacol. 55 (1999) 255-262
29. Gornikiewicz A., Sautner T., Brostjan C., Schmierer B., Fugger R., Roth E., Muhlbacher F., and Bergmann M. Catecholamines up-regulate lipopolysaccharide-induced IL-6 production in human microvascular endothelial cells. FASEB J. 14 (2000) 1093-1100
30. Goulding E.H., Ngai J., Kramer R.H., Colicos S., Axel R., Siegelbaum S.A., and Chess A. Molecular cloning and single-channel properties of the cyclic nucleotide-gated channel from catfish olfactory neurons. Neuron 8 (1992) 45-58
31. Green H., and Kehinde O. Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells. Cell 7 (1976) 105-113
32. Guan X.M., Amend A., and Strader C.D. Determination of structural domains for G protein coupling and ligand binding in beta 3-adrenergic receptor. Mol. Pharmacol. 48 (1995) 492-498
33. Hai T., and Hartman M.G. The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 273 (2001) 1-11
34. Hoch M., Eberle A.N., Peterli R., Peters T., Seboek D., Keller U., Muller B., and Linscheid P. LPS induces interleukin-6 and interleukin-8 but not tumor necrosis factor-alpha in human adipocytes. Cytokine 41 (2008) 29-37
35. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 444 (2006) 860-867
36. Hu F.B., Meigs J.B., Li T.Y., Rifai N., and Manson J.E. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53 (2004) 693-700
37. Hutchinson D.S., Bengtsson T., Evans B.A., and Summers R.J. Mouse beta 3a- and beta 3b-adrenoceptors expressed in Chinese hamster ovary cells display identical pharmacology but utilize distinct signalling pathways. Br. J. Pharmacol. 135 (2002) 1903-1914
38. Isakov N., and Altman A. Protein kinase C(theta) in T cell activation. Annu. Rev. Immunol. 20 (2002) 761-794
39. Jung B.D., Kimura K., Kitamura H., Makondo K., Okita K., Kawasaki M., and Saito M. Norepinephrine stimulates interleukin-6 mRNA expression in primary cultured rat hepatocytes. J. Biochem. 127 (2000) 205-209
40. Kageyama K., and Suda T. Urocortin-related peptides increase interleukin-6 output via cyclic adenosine 5′-monophosphate-dependent pathways in A7r5 aortic smooth muscle cells. Endocrinology 144 (2003) 2234-2241
41. Kamimura D., Ishihara K., and Hirano T. IL- 6 signal transduction and its physiological roles: the signal orchestration model. Rev. Physiol. Biochem. Pharmacol. 149 (2003) 1-38
42. Kawasaki H., Song J., Eckner R., Ugai H., Chiu R., Taira K., Shi Y., Jones N., and Yokoyama K.K. p300 and ATF-2 are components of the DRF complex, which regulates retinoic acid- and E1A-mediated transcription of the c-jun gene in F9 cells. Genes Dev. 12 (1998) 233-245
43. Kawasaki H., Springett G.M., Mochizuki N., Toki S., Nakaya M., Matsuda M., Housman D.E., and Graybiel A.M. A family of cAMP-binding proteins that directly activate Rap1. Science 282 (1998) 2275-2279
44. Kern P.A., Ranganathan S., Li C., Wood L., and Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 280 (2001) E745-E751
45. Kishimoto T. Interleukin-6: from basic science to medicine-40 years in immunology. Annu. Rev. Immunol. 23 (2005) 1-21
46. Klein P.S., Sun T.J., Saxe III C.L., Kimmel A.R., Johnson R.L., and Devreotes P.N. A chemoattractant receptor controls development in Dictyostelium discoideum. Science 241 (1988) 1467-1472
47. Li B., Kaetzel M.A., and Dedman J.R. Signaling pathways regulating murine cardiac CREB phosphorylation. Biochem. Biophys. Res. Commun. 350 (2006) 179-184
48. Liebregts T., Adam B., Bredack C., Roth A., Heinzel S., Lester S., Downie-Doyle S., Smith E., Drew P., Talley N.J., and Holtmann G. Immune activation in patients with irritable bowel syndrome. Gastroenterology 132 (2007) 913-920
49. Lim J.Y., Park S.J., Hwang H.Y., Park E.J., Nam J.H., Kim J., and Park S.I. TGF-beta1 induces cardiac hypertrophic responses via PKC-dependent ATF-2 activation. J. Mol. Cell. Cardiol. 39 (2005) 627-636
50. Lindquist J.M., Fredriksson J.M., Rehnmark S., Cannon B., and Nedergaard J. Beta 3- and alpha1-adrenergic Erk1/2 activation is Src- but not Gi-mediated in Brown adipocytes. J. Biol. Chem. 275 (2000) 22670-22677
51. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001) 402-408
52. Mathvink R.J., Tolman J.S., Chitty D., Candelore M.R., Cascieri M.A., Colwell Jr. L.F., Deng L., Feeney W.P., Forrest M.J., Hom G.J., MacIntyre D.E., Miller R.R., Stearns R.A., Tota L., Wyvratt M.J., Fisher M.H., and Weber A.E. Discovery of a potent, orally bioavailable beta(3) adrenergic receptor agonist, (R)-N-[4-[2-[[2-hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4-[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide. J. Med. Chem. 43 (2000) 3832-3836
53. May M.J., D'Acquisto F., Madge L.A., Glockner J., Pober J.S., and Ghosh S. Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 289 (2000) 1550-1554
54. Mizuno K., Kanda Y., Kuroki Y., Nishio M., and Watanabe Y. Stimulation of beta(3)-adrenoceptors causes phosphorylation of p38 mitogen-activated protein kinase via a stimulatory G protein-dependent pathway in 3T3-L1 adipocytes. Br. J. Pharmacol. 135 (2002) 951-960
55. Mizuno K., Kanda Y., Kuroki Y., Tomiyama K., and Watanabe Y. Phosphorylation of extracellular signal-regulated kinases 1 and 2 in 3T3-L1 adipocytes by stimulation of beta(3)-adrenoceptor. Eur. J. Pharmacol. 385 (1999) 63-69
56. Mizuno K., Kanda Y., Kuroki Y., and Watanabe Y. The stimulation of beta(3)-adrenoceptor causes phosphorylation of extracellular signal-regulated kinases 1 and 2 through a G(s)- but not G(i)-dependent pathway in 3T3-L1 adipocytes. Eur. J. Pharmacol. 404 (2000) 63-68
57. Mohamed-Ali V., Flower L., Sethi J., Hotamisligil G., Gray R., Humphries S.E., York D.A., and Pinkney J. beta-Adrenergic regulation of IL-6 release from adipose tissue: in vivo and in vitro studies. J. Clin. Endocrinol. Metab. 86 (2001) 5864-5869
58. Mohamed-Ali V., Goodrick S., Rawesh A., Katz D.R., Miles J.M., Yudkin J.S., Klein S., and Coppack S.W. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J. Clin. Endocrinol. Metab. 82 (1997) 4196-4200
59. Morton S., Davis R.J., and Cohen P. Signalling pathways involved in multisite phosphorylation of the transcription factor ATF-2. FEBS Lett. 572 (2004) 177-183
60. Moule S.K., and Denton R.M. The activation of p38 MAPK by the beta-adrenergic agonist isoproterenol in rat epididymal fat cells. FEBS Lett. 439 (1998) 287-290
61. Myung J., Kim K.B., and Crews C.M. The ubiquitin-proteasome pathway and proteasome inhibitors. Med. Res. Rev. 21 (2001) 245-273
62. Nackley A.G., Faison J.M., Lambeth B.L., Diatchenko L., and Maixner W. Catechol-O-Methyltransferase Modulates Pain Behavior and Cytokine Production via Beta2/3-Adrenergic Receptor Mechanisms (2005), Society for Neuroscience, Washington, DC
63. Nackley A.G., Tan K.S., Fecho K., Flood P., Diatchenko L., and Maixner W. Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors. Pain 128 (2007) 199-208
64. Norris J.G., and Benveniste E.N. Interleukin-6 production by astrocytes: induction by the neurotransmitter norepinephrine. J. Neuroimmunol. 45 (1993) 137-145
65. Norris J.G., Tang L.P., Sparacio S.M., and Benveniste E.N. Signal transduction pathways mediating astrocyte IL-6 induction by IL-1 beta and tumor necrosis factor-alpha. J. Immunol. 152 (1994) 841-850
66. Papanicolaou D.A., Petrides J.S., Tsigos C., Bina S., Kalogeras K.T., Wilder R., Gold P.W., Deuster P.A., and Chrousos G.P. Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines. Am. J. Physiol. 271 (1996) E601-E605
67. Parmee E.R., Brockunier L.L., He J., Singh S.B., Candelore M.R., Cascieri M.A., Deng L., Liu Y., Tota L., Wyvratt M.J., Fisher M.H., and Weber A.E. Tetrahydroisoquinoline derivatives containing a benzenesulfonamide moiety as potent, selective human beta3 adrenergic receptor agonists. Bioorg. Med. Chem. Lett. 10 (2000) 2283-2286
68. Path G., Bornstein S.R., Gurniak M., Chrousos G.P., Scherbaum W.A., and Hauner H. Human breast adipocytes express interleukin-6 (IL-6) and its receptor system: increased IL-6 production by beta-adrenergic activation and effects of IL-6 on adipocyte function. J. Clin. Endocrinol. Metab. 86 (2001) 2281-2288
69. Ray A., Tatter S.B., May L.T., and Sehgal P.B. Activation of the human "beta 2-interferon/hepatocyte-stimulating factor/interleukin 6" promoter by cytokines, viruses, and second messenger agonists. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 6701-6705
70. Robidoux J., Kumar N., Daniel K.W., Moukdar F., Cyr M., Medvedev A.V., and Collins S. Maximal beta3-adrenergic regulation of lipolysis involves Src and epidermal growth factor receptor-dependent ERK1/2 activation. J. Biol. Chem. 281 (2006) 37794-37802
71. Rockman H.A., Koch W.J., and Lefkowitz R.J. Seven-transmembrane-spanning receptors and heart function. Nature 415 (2002) 206-212
72. Romanov S., Medvedev A., Gambarian M., Poltoratskaya N., Moeser M., Medvedeva L., Diatchenko L., and Makarov S. Homogeneous reporter system enables quantitative functional assessment of multiple transcription factors. Nat. Methods 5 (2008) 253-260
73. Sato M., Hutchinson D.S., Evans B.A., and Summers R.J. Functional domains of the mouse beta(3)-adrenoceptor associated with differential G-protein coupling. Biochem. Soc. Trans. 35 (2007) 1035-1037
74. Shigemoto-Mogami Y., Koizumi S., Tsuda M., Ohsawa K., Kohsaka S., and Inoue K. Mechanisms underlying extracellular ATP-evoked interleukin-6 release in mouse microglial cell line, MG-5. J. Neurochem. 78 (2001) 1339-1349
75. Skurk T., Alberti-Huber C., Herder C., and Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J. Clin. Endocrinol. Metab. 92 (2007) 1023-1033
76. Slavin B.G., and Ballard K.W. Morphological studies on the adrenergic innervation of white adipose tissue. Anat. Rec. 191 (1978) 377-389
77. Soeder K.J., Snedden S.K., Cao W., Della Rocca G.J., Daniel K.W., Luttrell L.M., and Collins S. The beta3-adrenergic receptor activates mitogen-activated protein kinase in adipocytes through a Gi-dependent mechanism. J. Biol. Chem. 274 (1999) 12017-12022
78. Standaert M.L., Galloway L., Karnam P., Bandyopadhyay G., Moscat J., and Farese R.V. Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport. J. Biol. Chem. 272 (1997) 30075-30082
79. Takaki A., Huang Q.H., Somogyvari-Vigh A., and Arimura A. Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines. Neuroimmunomodulation 1 (1994) 335-342
80. Tan K.S., Nackley A.G., Satterfield K., Maixner W., Diatchenko L., and Flood P.M. Beta2 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA- and NF-kappaB-independent mechanisms. Cell. Signal. 19 (2007) 251-260
81. Tan Y., Rouse J., Zhang A., Cariati S., Cohen P., and Comb M.J. FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J. 15 (1996) 4629-4642
82. Tentolouris N., Liatis S., and Katsilambros N. Sympathetic system activity in obesity and metabolic syndrome. Ann. N. Y. Acad. Sci. 1083 (2006) 129-152
83. Thorand B., Baumert J., Kolb H., Meisinger C., Chambless L., Koenig W., and Herder C. Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Diabetes Care 30 (2007) 854-860
84. Togo T. Long-term potentiation of wound-induced exocytosis and plasma membrane repair is dependent on cAMP-response element-mediated transcription via a protein kinase C- and p38 MAPK-dependent pathway. J. Biol. Chem. 279 (2004) 44996-45003
85. Trautwein C., Caelles C., van der Geer P., Hunter T., Karin M., and Chojkier M. Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain. Nature 364 (1993) 544-547
86. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., Kales A., Tyson K., and Chrousos G.P. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J. Clin. Endocrinol. Metab. 82 (1997) 1313-1316
87. Vicennati V., Vottero A., Friedman C., and Papanicolaou D.A. Hormonal regulation of interleukin-6 production in human adipocytes. Int. J. Obes. Relat. Metab. Disord. 26 (2002) 905-911
88. Wellen K.E., and Hotamisligil G.S. Inflammation, stress, and diabetes. J. Clin. Invest. 115 (2005) 1111-1119
89. Wilkinson S.E., Parker P.J., and Nixon J.S. Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem. J. 294 Pt 2 (1993) 335-337
90. Wirsen C., and Hamberger B. Catecholamines in brown fat. Nature 214 (1967) 625-626
91. Yamaoka S., Courtois G., Bessia C., Whiteside S.T., Weil R., Agou F., Kirk H.E., Kay R.J., and Israel A. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 93 (1998) 1231-1240
92. Yin F., Wang Y.Y., Du J.H., Li C., Lu Z.Z., Han C., and Zhang Y.Y. Noncanonical cAMP pathway and p38 MAPK mediate beta2-adrenergic receptor-induced IL-6 production in neonatal mouse cardiac fibroblasts. J. Mol. Cell. Cardiol. 40 (2006) 384-393
93. Yuan J., Bae D., Cantrell D., Nel A.E., and Rozengurt E. Protein kinase D is a downstream target of protein kinase Ctheta. Biochem. Biophys. Res. Commun. 291 (2002) 444-452
94. Zhou D., Kusnecov A.W., Shurin M.R., DePaoli M., and Rabin B.S. Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology 133 (1993) 2523-2530
95. Zhu Z., Tang W., Ray A., Wu Y., Einarsson O., Landry M.L., Gwaltney Jr. J., and Elias J.A. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation. J. Clin. Invest. 97 (1996) 421-430
96. Zmuda-Trzebiatowska E., Manganiello V., and Degerman E. Novel mechanisms of the regulation of protein kinase B in adipocytes; implications for protein kinase A, Epac, phosphodiesterases 3 and 4. Cell. Signal. 19 (2007) 81-86